[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pyknodysostosis, a lysosomal disease caused by cathepsin K deficiency.  Science.1996;273:1236-1238.Google Scholar
Vesa J, Hellsten E, Verkruyse LA.  et al.  Mutations in the palmityl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis.  Nature.1995;376:584-587.Google Scholar
Hellsten E, Vesa J, Olkkonen VM, Jalanko A, Peltonen L. Human palmityl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis.  EMBO J.1996;15:5240-5245.Google Scholar
Sleat DE, Donnelly RJ, Lackland H.  et al.  Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis.  Science.1997;277:1802-1805.Google Scholar
Beutler E, Grabowski GA. Gaucher disease. In: Scriver CR, Beaudet AC, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. Vol 2. 7th ed. New York, NY: McGraw-Hill Book Co; 1995:2641-2670.
Hopwood JJ, Brooks DA. An introduction to the basic science and biology of the lysosome and storage diseases. In: Applegarth DA, Dimmick JE, Hall JG, eds. Organelle Diseases. New York, NY: Chapman & Hall; 1997:7-35.
Petersen GM, Rotter JI, Cantor RM.  et al.  The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.  Am J Hum Genet.1983;35:1258-1269.Google Scholar
Arvio M, Autio S, Louhiala P. Early clinical symptoms and incidence of aspartylglycosaminuria in Finland.  Acta Paediatr.1993;82:587-589.Google Scholar
van de Kamp JJ, Niermeijer MF, von Figura K, Giesberts MA. Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (types A, B, and C).  Clin Genet.1981;20:152-160.Google Scholar
Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY. An update on the frequency of mucopolysaccharide syndromes in British Columbia.  Hum Genet.1990;85:389-390.Google Scholar
Ozand PT, Gascon G, al Aqeel A, Roberts G, Dhalla M, Subramanyam SB. Prevalence of different types of lysosomal storage diseases in Saudi Arabia.  J Inherit Metab Dis.1990;13:849-861.Google Scholar
Krasnopolskaya KD, Mirenburg TV, Aronovich EL.  et al.  Diagnosis and prevention of lysosomal storage diseases in Russia [published erratum appears in J Inherit Metab Dis. 1994;17:111].   J Inherit Metab Dis.1993;16:994-1002.Google Scholar
Czartoryska B, Tylki Szymanska A, Gorska D, Sawnor Korszynska D. Lipidoses detected in Poland through 1993.  Pediatr Neurol.1994;11:295-297.Google Scholar
Michelakakis H, Dimitriou E, Tsagaraki S, Giouroukos S, Schulpis K, Bartsocas CS. Lysosomal storage diseases in Greece.  Genet Couns.1995;6:43-47.Google Scholar
Coelho JC, Wajner M, Burin MG, Vargas CR. Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism.  Eur J Pediatr.1997;156:650-654.Google Scholar
Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AC, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. Vol 2. 7th ed. New York, NY: McGraw-Hill Book Co; 1995:2465-2494.
Meikle PJ, Brooks DA, Ravenscroft EM.  et al.  Diagnosis of lysosomal storage disorders: evaluation of a lysosome-associated membrane protein LAMP-1 as a diagnostic marker.  Clin Chem.1997;43:1325-1335.Google Scholar
Rider JA, Rider DL. Batten disease: past, present, and future.  Am J Med Genet Suppl.1988;5:21-26.Google Scholar
Claussen M, Heim P, Knispel J, Goebel HH, Kohlschutter A. Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders.  Am J Med Genet.1992;42:536-538.Google Scholar
Santavuori P. Neuronal ceroid-lipofuscinoses in childhood.  Brain Dev.1988;10:80-83.Google Scholar
Original Contribution
January 20, 1999

Prevalence of Lysosomal Storage Disorders

Author Affiliations

Author Affiliations: Lysosomal Diseases Research Unit and National Referral Laboratory, Department of Chemical Pathology, Women's and Children's Hospital, Adelaide, Australia (Drs Meikle, Hopwood, and Carey); and the Division of Chemical Pathology, Royal Brisbane Hospitals Campus, Queensland Health Pathology Service, Brisbane, Australia (Dr Clague).

JAMA. 1999;281(3):249-254. doi:10.1001/jama.281.3.249

Context Lysosomal storage disorders represent a group of at least 41 genetically distinct, biochemically related, inherited diseases. Individually, these disorders are considered rare, although high prevalence values have been reported in some populations. These disorders are devastating for individuals and their families and result in considerable use of resources from health care systems; however, the magnitude of the problem is not well defined. To date, no comprehensive study has been performed on the prevalence of these disorders as a group.

Objective To determine the prevalence of lysosomal storage disorders individually and as a group in the Australian population.

Design Retrospective case studies.

Setting Australia, from January 1, 1980, through December 31, 1996.

Main Outcome Measure Enzymatic diagnosis of a lysosomal storage disorder.

Results Twenty-seven different lysosomal storage disorders were diagnosed in 545 individuals. The prevalence ranged from 1 per 57,000 live births for Gaucher disease to 1 per 4.2 million live births for sialidosis. Eighteen of 27 disorders had more than 10 diagnosed cases. As a group of disorders, the combined prevalence was 1 per 7700 live births. There was no significant increase in the rate of either clinical diagnoses or prenatal diagnoses of lysosomal storage disorders during the study period.

Conclusions Individually, lysosomal storage disorders are rare genetic diseases. However, as a group, they are relatively common and represent an important health problem in Australia.